RTsafe is among the 25 semi-finalists of the Massachusetts Institute of Technology (MIT) enterprise forum competition.

RTsafe has been selected for the first time for patient-specific pre-treatment plan verification of a pediatric cranial VMAT case.

RTsafe has announced the opening of its first production facility in the USA. In October 2015 RTsafe will be opening a polymer gel dosimetry lab in San Antonio, Texas.